BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6704206)

  • 21. Induction of peroxidase in the rat uterus under various endocrine conditions.
    Jellinck PH; Newcombe AM
    J Endocrinol; 1977 Jul; 74(1):147-8. PubMed ID: 874412
    [No Abstract]   [Full Text] [Related]  

  • 22. Distinction between malignant and normal breast tissue based on endogenous mediators of estradiol binding.
    Fishman JH; Fishman J
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1131-7. PubMed ID: 3342061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estradiol derivatives: relationship between uterotrophic activity and affinity to the cytosol receptor].
    Tang ZM; Chen MY; Zhang Q
    Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):186-91. PubMed ID: 6228119
    [No Abstract]   [Full Text] [Related]  

  • 24. [3H-estradiol binding to cytosol receptors of the rat olfactory epithelium].
    Parfenova EV
    Tsitologiia; 1986 May; 28(5):570-3. PubMed ID: 3738991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oestradiol on the induction of peroxidase in various tissues of the immature rat.
    Jellinck PH; Newcombe AM
    J Endocrinol; 1978 Feb; 76(2):393-4. PubMed ID: 627832
    [No Abstract]   [Full Text] [Related]  

  • 26. Discrete early changes in cellular subpopulations of rat uterine and anterior pituitary estrogen receptors in response to acute exposure to exogenous estradiol.
    Copland JA; Smanik EJ; Muldoon TG
    J Steroid Biochem; 1987 Jun; 26(6):723-31. PubMed ID: 3613573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxidases induced in rat uterus by estrogen administration. II. Cytochemical and biochemical heterogeneity.
    Anderson WA; Gabriel BW; Nerurkar SG; Wyche JH; Yates PE; Hanker JS
    J Submicrosc Cytol; 1986 Oct; 18(4):683-90. PubMed ID: 3783793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptors and androgen receptors in the mammalian liver.
    Eisenfeld AJ; Aten RF
    J Steroid Biochem; 1987; 27(4-6):1109-18. PubMed ID: 3320548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short term nuclear retention and early cytosol replenishment of estradiol receptors in uteri of ovariectomized diabetic rats after intraperitoneal injection of 17 beta-estradiol: evidence for decreased hormonal activity on protein synthesis.
    Ekka E; Vanderheyden I; De Hertogh R
    Endocrinology; 1982 Aug; 111(2):456-61. PubMed ID: 7094880
    [No Abstract]   [Full Text] [Related]  

  • 32. Partial characterization of protease(s) in human breast cancer cytosols that can degrade estrogen and progesterone receptors selectively.
    Maeda K; Tsuzimura T; Nomura Y; Sato B; Matsumoto K
    Cancer Res; 1984 Mar; 44(3):996-1001. PubMed ID: 6362861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
    Chilton BS; Williams ND; Cobb AD; Leavitt WW
    Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of nafoxidine (U-11,100A) on the induction of uterine peroxidase.
    McNabb T; Jellinck PH
    Steroids; 1976 May; 27(5):681-9. PubMed ID: 181872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyanoketone competition with estradiol for binding to the cytosolic estrogen receptor.
    Wolfson AJ; Richards J; Rotenstein D
    J Steroid Biochem; 1983 Dec; 19(6):1817-8. PubMed ID: 6672462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogens, estradiol receptors and peroxidase activity in human mammary carcinomas.
    Duffy MJ; O'Connell M
    Eur J Cancer (1965); 1981 Jun; 17(6):711-4. PubMed ID: 7308267
    [No Abstract]   [Full Text] [Related]  

  • 38. Androgen and estrogen receptors in the cytosol from male rat anterior hypophysis: further characteristics and differentiation between androgen and estrogen receptors.
    Mercier L; le Guellec C; Thieulant ML; Samperez S; Jouan P
    J Steroid Biochem; 1976 Oct; 7(10):779-85. PubMed ID: 1011836
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation of peroxidase activity in human breast cancer with oestradiol and progesterone receptors.
    Liel Y; Marbach M; Bearman JE; Feldman B; Glick SM; Levy J
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1389-90. PubMed ID: 6891935
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulation of uterine steroid receptor levels and peroxidase activity during the puerperium of the nonlactating rat.
    Keeping HS; Lyttle CR
    Biol Reprod; 1982 Nov; 27(4):1011-22. PubMed ID: 7171662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.